<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">178</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2018-17-2-76-83</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Usage of heteropolysaccharides to restore the skin barrier function in patients with chronic "graft versus host" disease</article-title><trans-title-group xml:lang="ru"><trans-title>Опыт применения гетерополисахаридовс целью восстановления барьерной функции кожи у пациентов с хронической реакцией «трансплантат против хозяина»</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2156-5487</contrib-id><name-alternatives><name xml:lang="en"><surname>Rassokhina</surname><given-names>O. I.</given-names></name><name xml:lang="ru"><surname>Рассохина</surname><given-names>О.И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>assistant of the Department of Skin Diseases and Cosmetology</p><p>Russia 117997, Moscow, Ostrovitianov st., 1</p></bio><email>olga-shuginina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0231-1617</contrib-id><name-alternatives><name xml:lang="en"><surname>Trakhtman</surname><given-names>P. E.</given-names></name><name xml:lang="ru"><surname>Трахтман</surname><given-names>П.Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9331-7714</contrib-id><name-alternatives><name xml:lang="en"><surname>Potekaev</surname><given-names>N. N.</given-names></name><name xml:lang="ru"><surname>Потекаев</surname><given-names>Н.Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian National Research Medical University named after N.I. Pirogov</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-09-20" publication-format="electronic"><day>20</day><month>09</month><year>2018</year></pub-date><volume>17</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>76</fpage><lpage>83</lpage><history><date date-type="received" iso-8601-date="2018-09-20"><day>20</day><month>09</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1970, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1970, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/178">https://hemoncim.com/jour/article/view/178</self-uri><abstract xml:lang="en"><p>The article deals with the specific features of skin changes due to the chronical «graft-versus-host disease» (GVHD) reaction and practice of its drug-free modalities. This study involved 34 patients with skin manifestations of cGVHD, that were on the standard immunosuppressive therapy or extracorporeal photopheresis. The patients received non-invasive diagnostics of skin (high frequency ultrasound of skin, photodermatoscopy, sebumetry, corneometry), and also had their skin manifestations corrected with heteropolysaccharide. The outcome of the conducted study shows that rational topographical use of heteropolysaccharide on treatment of standard immunosuppressive therapy or extracorporeal photopheresis results in the recovery of epidermal barrier, bringing relief to personal discomfort as regressing the feeling of skin tightness and pruriency, fractional reduction of rash, which is confirmed by the data of the noninvasive methods of skin treatment. The noninvasive methods of valuating multifunctional skin health (high frequency ultrasound of skin, photodermatoscopy, sebumetry, corneometry) are applicable for case follow-up of patients with skin manifestations of сGVHD.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>skin manifestations of сGVHD</kwd><kwd>complication of HSCT</kwd><kwd>noninvasive diagnosis of the skin</kwd><kwd>ultrasound of the skin</kwd><kwd>dermoscopy</kwd><kwd>corneometry</kwd><kwd>sebusumetry</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хрРТПХ</kwd><kwd>осложнение ТГСК</kwd><kwd>кожные проявления хрРТПХ</kwd><kwd>неинвазивная диагностика кожи</kwd><kwd>УЗИ кожи</kwd><kwd>дерматоскопия</kwd><kwd>корнеометрия</kwd><kwd>себуметрия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Румянцев А.Г., Масчан А.А. Транс-плантация гемопоэтических стволовых клеток у детей. Руководство для врачей. - М.: ММИА, 2003.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Čeović R., Desnica L., Pulanić D., et al. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease: Croatian Medical Journal 2016; 57 (3): 229-38.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lee S.J. Classification systems for chronic graft-versus-host disease. Blood 2017; 129 (1): 30-7.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Peyraga G., Lizee T., Gustin P., Clement-Colmou K., Di Bartolo C., Supiot S., et al. Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI). Clin Transplant 2017; 31 (4): e12923.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Flowers M.E.D., Martin P.J. How We Treat Chronic Graft-versus-Host Disease. Blood 2015; 125 (4): 606-15.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Atkinson K. Clinical bone marrow and blood stem cell transplantation. Cambridge university press: 1999, 701-15, 993-1000.</mixed-citation></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Левашева С.В. Нарушение регуляции эпидермального барьера в формировании атопического дерматита и бронхиальной астмы у детей. Автореф. на соиск. уч. степ. канд. мед. наук. - Уфа, 2015.</mixed-citation><mixed-citation xml:lang="ru">Левашева С.В. Нарушение регуляции эпидермального барьера в формировании атопического дерматита и бронхиальной астмы у детей. Автореф. на соиск. уч. степ. канд. мед. наук. - Уфа, 2015.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><mixed-citation>Баррет-Хилл Фл. Косметическая химия для косметологов и дерматологов. - М.: Косметика и медицина, 2017, с. 232.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hillen U., Hausermann P., Massi D., Janin A., Wolff D., Lawitschka A., Greinix H., Meyer R., Ziemer M. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol 2015; 29 (5): 948-54.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gottlöber P Leiter U, Friedrich W, Bunjes D, Schulz A, Kerscher M, Peter RU. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography. J Eur Acad Dermatol Venereol 2003; 17 (4): 402-7.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Зимницкий А.Н., Башкатов С.А. Гликозаминогликаны в биохимических механизмах адаптации организма к некоторым физиологическим и патологическим состояниям. - М.: Глобус, 2004, с. 203.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Румянцев А.Г. Федеральные клинические рекомендации по лечению хРТПХ после трансплантации гемопоэтических стволовых клеток у детей. - НОДГО 2015: 15.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Гусева Н.Г. Системная склеродермия и псевдосклеродермические синдромы. - М.: Медицина, 1993: 266 с.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rennie Darryn. Nailfold dermatoscopy in general practice: Aust Fam Physician, 2015; 44 (11): 809-81.</mixed-citation></ref></ref-list></back></article>
